The new era of aspiration risk: The dilemma of GLP-1 receptor agonists

Jack Madden; Andrew Goyen

doi:10.26550/2209-1092.1291

The new era of aspiration risk: The dilemma of GLP-1 receptor agonists

Authors

Dr Jack D Madden Australian and New Zealand College of Anaesthetists (ANZCA)
Andrew K Goyen

DOI:

https://doi.org/10.26550/2209-1092.1291

Abstract

There is a new wave of aspiration risk heading towards our operating theatres in the coming years. The popular weight loss drugs, glucagon-like peptide (GLP-1) receptor agonists, are
providing us with new dilemmas in fasting guidelines and airway management. What does the anaesthetic team need to know?

Downloads

Published

08-03-2024

How to Cite

Madden, J., & Goyen, A. (2024). The new era of aspiration risk: The dilemma of GLP-1 receptor agonists. Journal of Perioperative Nursing, 37(1), 1–2. https://doi.org/10.26550/2209-1092.1291